Sign in to view content

Severity of Diabetic Retinopathy as an Independent Risk Factor for Cerebral Vascular Accidents, Myocardial Infarctions, and All-Cause Mortality

Bobeck S Modjtahedi, MD

Video
Published 2020

Related

Impact of Delayed Treatment in Diabetic Retinal Disease: Experience From VISTA/VIVID and PANORAMA
Sunil Srivastava, MD
Annual Meeting Talks
2021
Baseline DR Severity and Time to DME Resolution in Patients Treated With Ranibizumab in the RIDE and RISE Clinical Trials
Katherine E Talcott, MD
Annual Meeting Talks
2021
Clinical Outcomes of Eyes with Diabetic Macular Edema Switched from Aflibercept to Ranibizumab Therapy
Michael A Klufas, MD
On Demand Cases, Courses, and Papers
2019

Category: Diabetic Retinopathy

See more